Context: 11-ketotestosterone (11-KT) is a novel class of active androgen. However, the detail of its synthesis remains unknown for humans.
A ndrogens are sex steroid hormones that play a role in various physiological processes via pathways involving the androgen receptor (AR) (1) . Testosterone is the most important androgen and is produced from cholesterol in the gonads in a series of steps catalyzed by steroid P450 hydroxylases and hydroxysteroid dehydrogenase (2) . Although testosterone itself strongly activates AR-mediated transactivation, it is also converted to a more potent androgen, 5␣-dihydrotestosterone (DHT), by 5␣-reductase in male peripheral tissues. The androgen/AR pathway is essential for male physiology, reproduction, and the development of sexual characteristics (3) . Although androgens are traditionally viewed as male hormones, androgen/AR signaling is also important for optimal female reproduction and physiology (4, 5) . Because androgen levels reduce with aging before menopause, postmenopausal women suffer various symptoms by androgen insufficiency (5, 6) . On the other hand, androgen excess in women results in a variety of pathological conditions, including polycystic ovary syndrome and idiopathic hirsutism (7) . Therefore, proper androgen signaling is important for the health of women. In addition to androgenic actions, testosterone is also a precursor for estrogen. Aromatase (CYP19A1) converts testosterone into the most potent estrogen, 17␤estradiol (E 2 ). It activates 2 subtypes of estrogen receptors (ERs), ER␣ and ER␤, the expression patterns of which are tissue and cell specific. Adrenal gland also produces testosterone and high concentrations of weak androgens, such as dehydroepiandrosterone, dehydroepiandrosterone sulfate, androstenedione, 11␤-hydoxyandrostenedione (11-OHA), and 11␤-hydroxytestosterone , which are also precursors for stronger androgens in target tissues (8 -10) . In previous studies, we and others have reported that 11-ketotestosterone (11-KT) (International Union of Pure and Applied Chemistry name is 17-hydroxyandrost-4-ene-3,11-dione) is another class of active androgen that can be converted from testosterone and other weaker precursors (9 -11) .
Cytochrome P450 and 11␤-hydroxysteroid dehydrogenase types 1 and 2 (CYP11B1 and HSD11B2) play important roles in the 11-KT synthesis from testosterone (10, 11) . It is well known that these enzymes are involved in glucocorticoid synthesis and metabolism. CYP11B1 catalyzes the final step of glucocorticoid production in the adrenal gland (12, 13) , whereas HSD11B2 converts active glucocorticoids into inactive 11-ketosteroid forms, which are abundantly expressed in the kidney and placenta (14) . We have demonstrated that Cyp11b1 and Hsd11b2 are expressed in murine gonads and are involved in gonadotropin-induced 11-KT production (11). 11-KT can strongly activate mammalian AR-mediated transactivation. It was also reported that 11-KT can be detectable in human blood samples (9) . Thus, it is conceivable that 11-KT is common androgen in mammals, although the detail of its synthesis remains unknown. In the present study, we evaluated the production and properties of 11-KT in humans.
Materials and Methods

Cell culture and transfection
Human ovarian granulosa cell tumor-derived KGN cells (kindly donated by Dr Toshihiko Yanase, University of Fukuoka, Fukuoka, Japan) and MCF-7 cells were cultured in DMEM/Ham's F-12 medium supplemented with 10% fetal bovine serum (FBS). Human adrenocortical tumor-derived H295R cells were cultured in Opti-MEM supplemented with 2% Nuserum IV (BD Biosciences). Human Leydig cells were purchased from ScienCell Research Laboratories, which are sourced within the United States under protocols that have obtained Institutional Review Board (IRB) approval. They were cultured in Leydig Cell Meidum (ScienCell Research Laboratories). The research protocol using human materials was approved at the ethical committee of Asahikawa Medical University. H295R cells were transfected using an Amaxa Nucleofector Technology system (Lonza) as described (15) . KGN and MCF-7 cells were transfected using Lipofectamine LTX reagent (Life Technologies, Inc) and HilyMax (Dojindo Laboratories). One day before transfection, the cells were seeded on 24-well plates and cultured with phenol red-free medium supplemented with 10% charcoal/ dextran-stripped-FBS. After 24 hours of transfection, the cells were treated with vehicle (ethanol) or steroid hormones for 24 hours. Luciferase assays were performed as described previously (15, 16) . Each data point represents the mean of at least 4 independent experiments.
Adenovirus production and infection
Adenovirus vectors for ␤-galactosidase, green fluorescent protein (GFP), and steroidogenic factor-1 (SF-1) were prepared using the Adeno-X Expression System 1 (Takara), following the manufacturer's instructions as described (16) . Using these vectors, replication-defective recombinant adenoviruses were propagated and titered in HEK 293 cells. Then, they were used to infect KGN cells at multiplicity of infection 10. GFP-expressing adenovirus used as a transduction control during infection. Transduction efficiency and optimal concentrations of virus were determined by investigating GFP expression using fluorescent microscopy. At 48 hours after infection, cells were processed for RNA or protein extraction.
DNA microarray
Expression analysis by DNA microarray has been described elsewhere (17) . Briefly, labeled cRNA was prepared from KGN cells with adenovirus-mediated expression of ␤-galactosidase, GFP, or SF-1. After fragmentation of cRNA, hybridization was performed with a human U133 Plus 2.0 Affymetrix GeneChip (Affymetrix). The arrays were scanned using a Gene-Array scanner, and the data were generated by Affymetrix Microarray Suite 4.0. Data were analyzed using Subio Platform software. press.endocrine.org/journal/jcem
RT-PCR and quantitative (Q)-PCR
Total RNA from the cultured cells was extracted using Tri-Pure Isolation Reagent (Roche). Total RNA from human testis, ovary, adrenal, liver, and kidney was purchased from Takara Bio, Inc and Biochain Institute, Inc. RT-PCR and Q-PCR was performed as described (16, 18) . The RT-PCR products were electrophoresed on a 1.5% (wt/vol) agarose gel, and the resulting bands were visualized by staining with ethidium bromide. In Q-PCR, each gene expression was measured by real-time PCR and normalized with ␤-actin expression. The primers used for PCR are described in Supplemental Table 1 . The primers used for other genes were as described (16, 18) .
Western blot analysis
Extraction of total proteins from cultured cells and subsequent quantification were conducted as described previously (16) . Protein extract samples from each human tissue were purchased from BioChain Institute, Inc. Ovarian tissue donors were able to donate healthy organs and were of reproductive age (aged 30 -34 y). Each tissue sample was collected under strict IRB ethical consenting practices. Equal amounts of protein (20 g) were resolved using 12.5% SDS-PAGE and transferred to polyvinylidene difluoride membranes. Western blot analyses of HSD11B2, CYP11B1, AR, ␤-actin, and GAPDH were performed with antibodies directed against HSD11B2 (H-145; Santa Cruz Biotechnology, Inc), CYP11B1 (13) , AR (N-20; Santa Cruz Biotechnology, Inc), ␤-actin (C4; Santa Cruz Biotechnology, Inc), and GAPDH (6C5; Santa Cruz Biotechnology, Inc), respectively. Enhanced chemiluminescence Western blotting reagents (Bio-Rad Laboratories, Inc) were used for detection.
Plasmids
The pcDNA3 expressing HSD11B2 was generated by cloning the open reading frame of HSD11B2 into a pcDNA3 vector (Invitrogen). A Slp-ARU/Luc reporter and pQCXIP/human AR were prepared as described (11, 19) . The estrogen-response element (ERE)/Luc was constructed by inserting the oligonucleotides into a pGL4.24 plasmid (Promega Corp).
Immunohistochemistry
Immunohistochemistry was performed as described previously (11, 19) . Sections of human testis (from men aged 23 and 50 y) and ovary (from woman aged 19 and 34 y) were purchased from US Biomax, Inc and Biochain Institute, Inc. Sections were Figure 1 . SF-1 induces HSD11B2 expression and 11-KT production in KGN cells. KGN cells were infected with adenoviruses expressing GFP or SF-1. Induction of HSD11B2 mRNA (A) and protein (B) by SF-1. A, mRNA expression of HSD11B2 gene was analyzed by Q-PCR and normalized to ␤-actin expression. Data represent the mean Ϯ SEM of at least 3 independent experiments. B, Western blot analyses were performed with antibodies against HSD11B2 and GAPDH using the same lysates. C, Induction of the enzymes for the synthesis of testosterone, 11-KT, and E 2 was confirmed by Q-PCR. Data represent the mean Ϯ SEM of at least 3 independent experiments. D, 11-KT, testosterone, and E 2 levels in each group were measured by EIA. Data represent the mean Ϯ SEM of at least 3 independent experiments. Differences between groups are indicated by **, P Ͻ .01. subjected to the antigen retrieval technique with Dako Target Retrieval Solution (pH 9) (Dako Denmark A/S) and treated with anti-CYP11B1 (13) and anti-HSD11B2 (20) . They were then developed using a Vectastain Elite ABC kit (Vector Laboratories).
Human blood samples
Blood samples were collected in collection tubes containing heparin from the median cubital vein of 2 healthy women volunteers at University of Fukui Hospital in 2007. Plasma was separated by centrifugation at 1000g for 5 minutes. Other plasma samples were purchased from AllCells and ProMedDX. All plasma samples were collected under IRB-approved collection protocols and subject informed consent. The donors were 10 men (aged 32.1 Ϯ 7.8 y) and 10 women (aged 31.7 Ϯ 6.0 y). Plasma samples were stored at Ϫ80°C until assays. The research protocol for using human materials was approved by the Ethics Committee of the University of Fukui.
Measurements by enzyme immunoassays (EIAs) and liquid chromatography-tandem mass spectrometry (LC-MS/MS)
Concentrations of testosterone, 11-KT, and E 2 in culture media of KGN, H295R, and human Leydig cells were determined by competitive EIA (11, 19) . Each sample was diluted with EIA buffer and analyzed using progesterone, testosterone, 11-KT, and E 2 EIA kit (Cayman Chemical Co) following the manufacturer's instructions in a microplate reader (Molecular Device SpectraMax M5; Molecular Device, LLC). On the other hand, concentrations of steroid hormones in human plasma were measured by LC-MS/MS for optimal quantification of the clinical samples. Processing of human plasma samples and quantification of testosterone, 11-KT, and E 2 by LC-MS/MS are based on methods as described previously (9) .
Retrovirus preparation and infection
The Phoenix packaging cell line was transiently transfected with the retroviral plasmids using the FuGENE 6 reagent (Promega). The supernatant was concentrated by centrifugation. The virus solution was stored at Ϫ80°C until use. MCF-7 cells were infected with the retrovirus in the presence of 8-g/mL Polybrene (Sigma-Aldrich) for 48 hours. The cells were then replated and selected using puromycin.
Proliferation assay
MCF-7 cells or AR-introduced cells were seeded with DMEM/F-12 supplemented with 10% or 2% charcoal/dextranstripped-FBS at 1 ϫ 10 3 cells/well in 96-well plates. At 24 hours after seeding, the cells were treated with the media containing various concentrations of DHT, testosterone, 11-KT, or E 2 . Six days (parental cells) or 9 days (AR-introduced cells) after incubation, cell proliferation was evaluated using a CellTiter 96 Aqueous One Solution kit (Promega) following the manufacturer's instructions. To evaluate the effect of an aromatase inhibitor, fadrozole (Sigma) or an ER antagonist, fulvestrant (Sigma), on the growth of MCF-7 cells, a proliferation assay was performed with or without these agents.
Statistics
Data are presented as the mean Ϯ SEM. Differences between groups (P Ͻ .05) were assessed by the Student's t test or one-way ANOVA followed by Tukey's multiple comparison tests using EZR software (Saitama Medical Center, Jichi Medical University, Saitama, Japan) (21) , which is a graphical user interface for R (The R Foundation for Statistical Computing, Vienna, Austria).
Results
HSD11B2 is induced by SF-1 and involved in the 11-KT production
Human ovarian granulosa cell tumor-derived KGN cells have low steroidogenic capacity under basal conditions. However, they can be transformed to produce a range of steroid hormones by infection with an adenovirus expressing SF-1 and its coactivator (16) . To examine changes in gene expression in this transformation, we used a DNA microarray with GFP-or SF-1-introduced KGN press.endocrine.org/journal/jcem cells. SF-1 introduction induced a number of genes, including steroidogenic enzymes such as CYP11A1, HSD3B2, CYP17A1, and CYP19A1 (Supplemental Table  2 ), which are known SF-1 targets (22) . In addition to these genes, HSD11B2 was a strong SF-1-inducible candidate gene (Supplemental Table 2 ) and was almost undetectable in GFP-introduced cells (Figure 1, A and B) . Consistent with DNA microarray data, Q-PCR and immunoblotting analyses revealed that introduction of SF-1 strongly induced HSD11B2 mRNA and proteins ( Figure 1, A and B) .
In previous studies, it was demonstrated that HSD11B2 is involved in 11-KT production from testosterone with CYP11B1 (Supplemental Figure 1 ) in murine gonads (11, 19) or from adrenal androgens by in vitro analysis (10) . The DNA microarray analyses suggest that CYP11B1 is an SF-1-inducible gene, as well as other steroidogenic genes that are involved in testosterone and E 2 synthesis ( Figure  1C and Supplemental Table 2 , and Supplemental Figure  1 ). In fact, the introduction of SF-1 induced not only the production of testosterone and E 2 but also the CYP11B1 expression and 11-KT production ( Figure 1, C and D) .
To verify the role of HSD11B2 during 11-KT production in human steroidogenic cells, it was ectopically expressed in human adrenocortical H295R cells. H295R cells expressed CYP11B1 and other steroidogenic enzymes for testosterone synthesis (Supplemental Figure 2) , whereas endogenous HSD11B2 was undetectable ( Figure  2A ). Even though H295R cells produce testosterone at relatively high levels, its conversion to 11-KT was marginal ( Figure 2, C and D) . Transient transfection of the Western blot analysis is representative of the 2 experiments. C, Localization of CYP11B1 and HSD11B2 proteins in human gonads. Positive staining both for CYP11B1 and HSD11B2 was observed in testicular Leydig cells and ovarian theca cells. No staining was observed in control sections incubated with nonimmune serum. An, antrum. D, Production of testosterone and 11-KT by human Leydig cells with or without 8br-cAMP for 48 hours. Each androgen levels in each group were measured by EIA. Data represent the mean Ϯ SEM of at least 3 independent experiments. E-H, Levels of plasma testosterone, 11-KT, and E 2 in humans. Plasma testosterone (E), 11-KT (F), and E 2 (G) levels in men and women were measured by LC-MS/MS. In the box and whisker plots, boxes show 75th and 25th percentiles. Horizontal lines in the boxes represent the medians. Whiskers show the lowest values and the highest values. Differences between groups are indicated by *, P Ͻ .05 and **, P Ͻ .01. H, Comparison of plasma testosterone, 11-KT, and E 2 levels within each sex. Data represent the mean Ϯ SEM (n ϭ 10 men, n ϭ 10 women). Figure 2B ) markedly increased 11-KT production compared with the control group ( Figure 2D ), whereas testosterone concentrations were similar in both groups ( Figure 2C ). These results indicate that the expression of human HSD11B2 could be an important factor for the production of 11-KT in steroidogenic cells.
HSD11B2 expression vector (
11-KT is produced in gonads and is one of the major androgens in human
To elucidate the 11-KT synthesis pathway, we investigated the expression of CYP11B1 and HSD11B2 in human gonads (Figure 3, A and B) . Q-PCR and Western blot analyses showed that both genes were detectable in the testis and ovary at the mRNA and protein levels ( Figure 3,  A and B) . Immunohistochemical analysis showed that both proteins are localized on testicular Leydig cells and ovarian theca cells, even though HSD11B2 is also detectable in some populations of ovarian granulosa cells (Figure 3C) . These results strongly suggest that 11-KT is produced in testicular Leydig cells and ovarian theca cells. To confirm this hypothesis, we investigated the production of 11-KT in human Leydig cells. In support of the immnohistochemical analyses, Leydig cells expressed CYP11B1 and HSD11B2 genes (Supplemental Figure 3A) . They can produce progesterone, testosterone, and 11-KT under basal conditions ( Figure 3D and Supplemental Figure 3B ). cAMP treatment moderately increased the production of these steroid hormones.
Then, we measured plasma concentrations of 11-KT, testosterone, and E 2 in both sexes (Figure 3 , E-G). Testosterone levels in men were about 22-fold higher than those in women, whereas 11-KT levels were similar between the sexes (Figure 3 , E and F). It is noteworthy in women that 11-KT concentrations were similar to testosterone concentrations and about 5-fold higher than E 2 concentrations ( Figure 3H ). Human AR-mediated transactivation was significantly increased by 11-KT at concentrations more than 10 Ϫ9 M in KGN cells (Figure 4 ). This level is lower than that for the induction by other androgens, although transactivation was increased to similar levels by DHT and testosterone at 10 Ϫ8 M and 10 Ϫ7 M, respectively. These results suggest that 11-KT may play some roles in human as one of the major androgens.
11-KT is not convertible to estrogenic hormones
In female individuals, testosterone acts as both an androgen and a precursor for estrogen. To determine whether 11-KT is a precursor for estrogen, we performed a luciferase assay using a reporter plasmid containing the ERE in human breast cancer-derived MCF-7 cells, which endogenously express aromatase and ER␣. In contrast to E 2 , androgens had no effect on luciferase activity at lower concentrations (10 Ϫ11 M and 10 Ϫ10 M) ( Figure 5A ). However, testosterone activated ER-dependent transcription at high concentrations and at 10 Ϫ7 M testosterone was effective as E 2 . This activity was completely suppressed by an aromatase inhibitor, fadrozole ( Figure 5B ). DHT weakly activated ER-mediated transactivation in an aromatase-independent manner at 10 Ϫ7 M. In contrast, 11-KT had no effect on ER-mediated transactivation, even at 10 Ϫ6 M ( Figure 5A ; data not shown). These results indicate that 11-KT is a nonaromatizable androgen, and does not convert to a compound that activates ER-mediated transactivation.
Then, we assessed the effect of 11-KT on cell proliferation in MCF-7 cells. The proliferation of MCF-7 cells is highly dependent on estrogens. Consistent with previous studies, MCF-7 cells were increased by more than 10 Ϫ11 M E 2 ( Figure 6A ). In support of the reporter assays result, testosterone significantly stimulated cell proliferation at higher concentrations ( Figure 6A) , and fadrozole and the ER antagonist fulvestrant completely inhibited testosterone-induced cell proliferation ( Figure 6 , B and C). Conversely, 11-KT had no effect on cell growth at any concentration, similar to DHT. These results strongly suggest that 11-KT acts as a stable androgen in both AR-and aromatase-positive cells. To further test this hypothesis, AR was stably transfected into MCF-7 cells ( Figure 6D ) and we measured the AR-mediated growth inhibition of each androgen. Consistent with previous reports (23), DHT strongly suppressed cell proliferation in AR-introduced MCF-7 cells ( Figure 6E) . Similarly, 11-KT also in- press.endocrine.org/journal/jcem hibited proliferation, although to a lesser extent than DHT. In contrast, testosterone did not significantly inhibit cell growth.
Discussion
11-KT is one of the active androgens, which was originally characterized as a teleost-specific hormone. However, we and others have since noted that it is also present in mammals (9 -11) . Here, we found evidence that 11-KT is produced in human gonads and is one of the major androgens. It can potentially act as a nonaromatizable androgen. Testicular Leydig cells and ovarian theca cells expressed the enzymes for producing 11-KT from testosterone, CYP11B1 and HSD11B2. In fact, Leydig cells produced 11-KT, autonomously. HSD11B2 protects mineralocorticoid receptor from glucocorticoid by inactivating cortisol to corticosterone in aldosterone-sensitive tissues (14) . The gonads are target organs for mineralocorticoids, which express mineralocorticoid receptor (24, 25) . Mineralocorticoids can stimulate the production of testosterone and progesterone in testicular Leydig cells (24) and ovarian granulosa cells (26) , respectively. Conversely, glucocorticoids inhibit testicular and ovarian steroidogenesis (27) . Because HSD11B2 proteins are expressed in these cells, it is reasonable to assume that gonadal HSD11B2 plays a role in the protection of steroidogenic cells from the adverse effects of glucocorticoids. In addition to this classical role, the involvement of HSD11B2 in 11-KT production in Leydig cells and theca cells may represent another important role (10, 11) . Our results strongly suggest that the gonads are main organs for 11-KT production in humans by the expression of HSD11B2.
In mammals, CYP11B1 is thought to be an adrenalspecific enzyme that is essential for the final step of glucocorticoid synthesis (12) . However, it is also expressed in the testicular Leydig cells and ovarian theca cells to a lesser extent. There is also evidence that CYP21 is expressed in the gonads (25, 28) . Thus, a contribution of gonadal CYP11B1 to local glucocorticoid synthesis cannot be ruled out, although there are no studies documenting high levels of cortisol in the gonads. Rather, it is often reported that cortisol levels are lower in ovarian follicular fluid (FF) than in the blood (29, 30) . Therefore, it is conceivable that the production of precursors for 11-KT could be one of the most important functions of CYP11B1 in the gonads. Indeed, testosterone and androstenedione are efficiently converted to the 11-KT precursors (11-OHT and 11-OHA) by ectopic expression of human CYP11B1 with ferredoxin in COS-1 cells (10) . Consistent with this in vitro study, high levels of these steroids are produced in the CYP11B1-abundant adrenal gland, even though they are rarely converted to 11-keto products by low-level expression of HSD11B2 in the adrenal. However, it is probable that adrenal-derived 11-OHT and 11-OHA could be another sources of human 11-KT by the conversion in HSD11B2-expressing organs, including gonads.
There was no sexual dimorphism of human plasma 11-KT levels, even though testosterone levels were much higher in men. Similar phenomena were also observed in rodents (11) . This indicates that the dominance of 11-KT production in female is conserved between rodents and humans. In mice, the abundant expression of ovarian HSD11B2 is likely responsible for this dominance (11). In addition, the testicular expression of Hsd11b1 was much higher than in the ovary (11) . Because this 11␤-HSD isoform preferentially catalyzes the reduction of 11-ketosteroid (31), the difference in its expression between sexes also results in ovarian dominance of 11-KT production. Such sexual differences in the expression of both HSD11B1 (Y. Imamichi and T. Yazawa, unpublished data) and HSD11B2 were unclear in human gonads. In addition to the level of expression, the activity of 11␤-HSD enzymes is regulated by a number of factors (32, 33) . It is interesting that human ovarian FF contains the selective inhibitor for HSD11B1 (34) . Additionally, it was also reported that ovarian FF contains much higher concentrations of 11-OHA than plasma levels, which is converted from cortisol in granulosa cells (35) . This might be another pathway for ovarian 11-KT pro-duction. Further studies are needed to evaluate the sexual dimorphism of 11-KT production in humans.
DHT, testosterone, and 11-KT can strongly activate AR-mediated transactivation, even though there are some differences, especially at lower levels. Testosterone acts not only as an androgen but also as a precursor for estrogens. It can be converted to E 2 in aromatase-expressing cells and induces estrogen-dependent phenomena. Conversely, it is probable that 11-KT is not converted to estrogen by aromatase. Although DHT is also a nonaromatizable androgen, it can be converted to 3␤-diol by HSD17B7, which can bind to ERs (36) . Therefore, 11-KT likely represents extremely difficult androgen to convert to an estrogenic steroid. In addition, plasma 11-KT levels are similar to testosterone levels in women at reproductive age press.endocrine.org/journal/jcem and in menopausal women (9) . Thus, it is possible that 11-KT plays important roles in female, especially in ARand aromatase-expressing tissues such as ovary and breast. In a previous study, we demonstrated using mice that testosterone and 11-KT are elevated at ovulatory LH/ human chorionic gonadotropin stimulation and are involved in the expression of ovulation-related genes, such as cyclooxygenase-2 and amphiregulin, in granulosa cells (19) . This issue could be a subject of further investigation in human, because preovulatory follicles express CYP19A1 gene at high levels (37) . In summary, we demonstrated that 11-KT is a major androgen and produced in gonads. Because androgens are essential for reproduction and physiology, their excess and deficiency often induce pathogenesis. Then, it is possible that 11-KT could be responsible for, and the novel target of therapies against, such diseases. In addition, it might provide novel insights for elucidating ambiguous AR-mediated phenomena.
